Crossject【ALCJ】銘柄情報

Crossject (ALCJ) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.886

( -0.74% )

買値

1.88

売値

1.91

出来高

88,928

1.88 日の範囲 1.922

1.346 52 週間の範囲 2.695

時価総額

102.681M

前日終値

1.90

始値

1.922

時刻

110

1.886

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

354,731 €

発行済株式数

54,443,789

配当利回り

PER

-9.74

1 株当たり利益 (EPS)

-0.19

歳入

2.57M

純利益

-10.37M

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisi... Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.crossject.com

本社

Dijon, France

設立

2026

Crossject is listed in the Healthcare sector of the ユーロネクスト with ticker ALCJ. The last closing price for Crossject was 1.90 €. Over the last year, Crossject shares have traded in a share price range of 1.346 € to 2.695 €.

Crossject currently has 54,443,789 shares in issue. The market capitalisation of Crossject is 102.68 € million. Crossject has a price to earnings ratio (PE ratio) of -9.74.

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS CROSSJECT Société anonyme au capital social de 5 977 067,50 Euros Siège social : 6, rue Pauline...

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale CROSSJECT met à disposition les...

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million...

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit...

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory DIJON...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.042	-2.17842323651	1.928	2.03	1.88	222723	1.91756114	DE
4	-0.384	-16.9162995595	2.27	2.48	1.832	434743	2.10616621	DE
12	-0.09	-4.55465587045	1.976	2.58	1.832	385603	2.11298957	DE
26	-0.134	-6.63366336634	2.02	2.58	1.8	333642	2.09100498	DE
52	0.066	3.62637362637	1.82	2.695	1.346	300765	2.05341946	DE
156	-2.044	-52.010178117	3.93	5.96	0.7502	157194	2.24347373	DE
260	-1.244	-39.7444089457	3.13	5.96	0.7502	130122	2.56340988	DE